Pancreatic Cancer Research

ResearcherOsaka City UniversityNo recent work listed

Ryosuke Amano

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-1635-6605; OpenAlex author ID A5054786789. Sources: OpenAlex.

Their work

Papers
18 (first author 2, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
38
Papers, trials and grants by year

2011: 2 papers · 2012: none · 2013: 3 papers · 2014: 1 paper · 2015: 1 paper · 2016: 2 papers · 2017: 2 papers · 2018: 3 papers · 2019: none · 2020: 1 paper · 2021: none · 2022: 2 papers · 2023: 1 paper

Papers 18

  1. Pancreaticoduodenectomy with celiac artery resection (PD-CAR) for unresctable locally advanced pancreatic ductal adenocarcinoma. First author DOI 10.1007/s00423-023-02860-1↗
  2. Influence of a biliary stent in patients with advanced pancreatic cancer treated with modified FOLFIRINOX. Co-author DOI 10.1097/md.0000000000032150↗
  3. Optimal Organ for Patient-derived Xenograft Model in Pancreatic Cancer and Microenvironment that Contributes to Success. Co-author DOI 10.21873/anticanres.15718↗
  4. Establishment of a Liver Transplant Patient-derived Tumor Xenograft (PDX) Model Using Cryopreserved Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.21873/anticanres.14234↗
  5. Pancreatic Cancer Cell Fraction Estimation in a DNA Sample. Co-author DOI 10.1159/000491637↗
  6. MAPLE-PD trial (Mesenteric Approach vs. Conventional Approach for Pancreatic Cancer during Pancreaticoduodenectomy): study protocol for a multicenter randomize… Co-author DOI 10.1186/s13063-018-3002-z↗
  7. [A Case of Male Breast Cancer Suspected of Breast Metastasis from Pancreatic Cancer]. Co-author PMID 30692377↗
  8. Analysis of the origin of anaplastic pancreatic cancer and the mechanism of its dedifferentiation. Co-author DOI 10.1002/jhbp.429↗
  9. Preoperative predictors for early recurrence of resectable pancreatic cancer. Co-author DOI 10.1186/s12957-016-1078-z↗
  10. Establishment and characterization of new cell lines of anaplastic pancreatic cancer, which is a rare malignancy: OCUP-A1 and OCUP-A2. Co-author DOI 10.1186/s12885-016-2297-y↗
  11. Pancreatic Fibroblasts Stimulate the Motility of Pancreatic Cancer Cells through IGF1/IGF1R Signaling under Hypoxia. Co-author DOI 10.1371/journal.pone.0159912↗
  12. Pancreatectomy with major arterial resection after neoadjuvant chemoradiotherapy gemcitabine and S-1 and concurrent radiotherapy for locally advanced unresecta… Co-author DOI 10.1016/j.surg.2015.02.016↗
  13. Clinical and pathological features of five-year survivors after pancreatectomy for pancreatic adenocarcinoma. First author DOI 10.1186/1477-7819-12-360↗
  14. IGF-1 receptor and IGF binding protein-3 might predict prognosis of patients with resectable pancreatic cancer. Co-author DOI 10.1186/1471-2407-13-392↗
  15. In vitro effects of lapatinib with gemcitabine for pancreatic cancer cells. Co-author DOI 10.5754/hge13195↗
  16. [A case of locally advanced pancreatic cancer with hepatic artery invasion treated with neoadjuvant chemoradiotherapy]. Co-author PMID 24393948↗
  17. Identification of HLA-A*0201- and A*2402-restricted epitopes of mucin 5AC expressed in advanced pancreatic cancer. Co-author DOI 10.1097/mpa.0b013e31821ad8d1↗
  18. HER3 overexpression as an independent indicator of poor prognosis for patients with curatively resected pancreatic cancer. Co-author DOI 10.1159/000333825↗

Closest collaborators

The 25 strongest of 38 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Kenjiro Kimura · 16 shared papers, 2011–2023 · strength 1.16
  2. Kosei Hirakawa · 13 shared papers, 2011–2018 · strength 0.65
  3. Kohei Nishio · 6 shared papers, 2014–2023 · strength 0.55
  4. Masaichi Ohira · 9 shared papers, 2011–2020 · strength 0.49
  5. Sadaaki Yamazoe · 8 shared papers, 2011–2020 · strength 0.48
  6. Hiroji Shinkawa · 3 shared papers, 2020–2023 · strength 0.41
  7. Masakazu Yashiro · 5 shared papers, 2013–2022 · strength 0.37
  8. Ryota Tanaka · 2 shared papers, 2020–2022 · strength 0.23
  9. Shoji Kubo · 2 shared papers, 2020–2022 · strength 0.23
  10. Akihiro Murata · 5 shared papers, 2013–2016 · strength 0.20
  11. Takeaki Ishizawa · 1 shared paper, 2023 · strength 0.18
  12. Kotaro Miura · 3 shared papers, 2014–2017 · strength 0.16
  13. Toshiki Hirakawa · 4 shared papers, 2011–2016 · strength 0.16
  14. Shimpei Eguchi · 1 shared paper, 2022 · strength 0.13
  15. Yuki Ishikawa‐Kakiya · 1 shared paper, 2022 · strength 0.13
  16. Akie Kimura Yoshikawa · 1 shared paper, 2022 · strength 0.13
  17. Yasuhiro Fujiwara · 1 shared paper, 2022 · strength 0.13
  18. Hiroki Ishihara · 1 shared paper, 2018 · strength 0.07
  19. Norifumi Kawada · 1 shared paper, 2018 · strength 0.07
  20. Koji Takada · 1 shared paper, 2018 · strength 0.07
  21. Toshikazu Ushijima · 1 shared paper, 2018 · strength 0.07
  22. Yoshiaki Murakami · 1 shared paper, 2018 · strength 0.06
  23. Sohei Satoi · 1 shared paper, 2018 · strength 0.06
  24. Suguru Yamada · 1 shared paper, 2018 · strength 0.06
  25. Hidetoshi Eguchi · 1 shared paper, 2018 · strength 0.06

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.